Epidemiology and Treatment of Microbial Infections in Respiratory Diseases

Dear Colleagues,

Pulmonary infections remain a major global health concern, with a considerable impacts on morbidity, mortality, and healthcare systems, especially in low-resource settings. Accurate and timely epidemiological data are essential for tracking trends, identifying at-risk populations, and informing both clinical and public health responses. The recent emergence and spread of respiratory pathogens such as SARS-CoV-2 have highlighted the dynamic nature of pulmonary infections and the need for ongoing surveillance and adaptive strategies.

At the same time, treatment approaches continue to evolve in response to changes in pathogen profiles, antimicrobial resistance patterns, and advances in clinical care. Despite these developments, challenges remain in achieving optimal outcomes, particularly in the context of increasing multidrug resistance and the complexity of co-infections, especially in critically ill patients requiring treatment in the ICU.

This Special Issue welcomes original research and review articles that explore the epidemiology, risk factors, therapeutic strategies, and clinical outcomes of pulmonary infections. Contributions that shed light on infection trends, treatment efficacy, resistance mechanisms, and emerging interventions are especially encouraged.

We look forward to your submissions.

Dr. Marija Vukoja
Prof. Dr. Peđa Kovačević
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.